Cardihab selected for Amazon Web Services (AWS) Health Equity Program


Cardihab has been selected for a global program from Amazon Web Services (AWS), supporting organisations that are developing solutions to advance health equity.

Cardihab will receive computing credits and technical expertise from Amazon Web Services which will be used to further facilitate its digital cardiac rehabilitation platform.   Cardihab's digital programs are designed to help ensure the significant proportion of marginalised patients that should participate in cardiac rehabilitation but cannot due to common barriers—such as lack of transport, time constraints, competing work/life commitments, psychosocial factors etc— will have an alternative pathway to participation.

Through the program, AWS offers AWS credits and customised technical expertise to selected organisations around the world that want to use AWS services to improve health outcomes and health equity in any of the following areas:
1) increasing access to health services for underserved communities;
2) addressing social determinants of health;
3) leveraging data to promote more equitable and inclusive systems of care; and
4) advancing equity in diagnostics and screening

The support from AWS will advance Cardihab’s efforts to deliver more equitable access to care for those at risk of, or living with, cardiovascular disease (CVD).

In addition to delivering a high quality, flexible, guideline aligned cardiac rehabilitation program that can have a critical impact on patient outcomes, the Cardihab solution also establishes a dynamic dataset that includes observations, activity, medication and psychological metrics which are gained throughout the course of a rehab program.

Integration with wearable technology and objective measures entered by clinical staff create a comprehensive set of high-quality data that facilitates an AI supported feedback mechanism to personalise care for optimal outcomes. Data is mapped into FHIR resources for maximum interoperability.

“To be selected to be part of this program is a wonderful testament to the potential of the Cardihab solution to have an impact on how we deliver equitable patient care, and to improve patient outcomes in the future.  Our strong data solution is a key component in ensuring robust insights and key metrics are harnessed in an incisive and adaptable way, to help build sustainable care pathways”, said Cardihab CEO Helen Souris.

“AWS believes individual health outcomes should not depend on socioeconomic status, race, ethnicity, or neighbourhood, “said Maggie Carter, Global Lead, Social Impact at AWS. “Cloud technology can be a force multiplier when it comes to addressing the inequities in global health that have been amplified by the pandemic. Through this program, we look forward to helping Cardihab and other organisations worldwide use AWS to advance health equity and improve health outcomes.”

To learn more about the AWS program, visit

Cardihab partners with Australian Centre for Heart Health

WP_Aust Centre for Heart Health_Image

Cardihab is pleased to announce its partnership with the Australian Centre for Heart Health with the goal of supporting the mental health needs of patients who have experienced a cardiac event. The partnership will enable the Centre’s extensive library of clinical resources to be made available to those participating in Cardihab’s virtual cardiac rehabilitation programs.

The Australia Centre for Heart Health is an organisation dedicated to supporting people who have had a cardiac event in their psychological, social and behavioural recovery.

The Centre’s range of evidence-based resources have been developed from its own world-leading research, as well as that of other experts in cardiac-related behavioural and psychological support.

Each year, around 54,000 Australians have a heart attack and up to 75% of survivors experience the ‘cardiac blues’ during recovery, a phenomenon which is characterised by a range of distressing and often debilitating emotional, behavioural and cognitive changes. Typical emotions include anxiety, fear and worry; anger, irritation and frustration; distress, sadness and depression; guilt and denial¹.

Resources developed by the Australian Centre for Heart Health address conditions such as the cardiac blues, as well as other common mental health issues faced by patients, helping to build awareness and provide strategies to develop resilience to overcome these issues.

Cardihab CEO Helen Souris says the partnership was integral to Cardihab’s ongoing commitment to delivering exceptional patient care plans and support.

“The psychosocial impact of a cardiac event is significant but can often be underestimated.   Emotional recovery is as important as physical recovery in ensuring people can effectively return to their lives, and we know the Australian Centre for Heart Health resources will go a long way in helping clinicians and patients to understand and navigate this aspect of the recovery journey”.

Australia Centre for Heart Health Director Prof. Alun Jackson is pleased to be extending their clinical content and expertise to more patients through this partnership.

“It’s a great collaboration to help ensure cardiac patients are receiving high-quality, evidence-based care in terms of mental health resources and support.  We’re pleased to be able to extend our programs through Cardihab’s digital therapeutic platform, to ensure we maximise reach and patient outcomes.”

Learn more about the Australian Centre for Heart Health here or contact us to learn more about this collaboration.

1. The ‘cardiac blues’: A guide for health professionals, The Australian Centre for Heart Health; The Red Flags Project

Partnership between Cardihab and Roche Diagnostics Australia Pty Ltd announced

Roche Partnership (1)

Roche Diagnostics Australia Pty Ltd and Cardihab Pty Ltd are proud to announce a partnership that is focused on improving quality and standards of care, that deliver better outcomes for people living with cardiovascular conditions in Australia.

Roche sees this partnership as an integral part of their mission to deliver value-based health care along the entire patient journey, from diagnosis, through treatment and monitoring. An optimised care approach for people living with cardiovascular disease (CVD) has the potential to provide an improved care pathway that has been shown to reduce rates of hospital readmission, costs, and the burden of disease on patients quality of life.

Allison Rossiter, Managing Director of Roche Diagnostics Australia said that "We are committed to improving care access and outcomes for cardiac patients across Australia by leveraging our strengths and augmenting our offerings to deliver patient centric integrated solutions. We see Cardihab as a great organisation to collaborate with in realising this vision.”

Cardihab CEO, Helen Souris says: “We are thrilled to partner with Roche, who share our passion for making a difference to the way care is delivered in Australia, and who value collaboration to drive change through innovative approaches. The complementary nature of Roche’s diagnostic portfolio together with Cardihab’s digital therapeutic solutions will accelerate our ability to realise our purpose of providing patients with the care they need in ways that work for them.”

Cardiovascular disease refers to a class of conditions that affect the heart and blood vessels, including coronary heart disease, stroke and heart failure.

Cardiovascular disease is one of the leading causes of death and disability in Australia. According to the Australian Bureau of Statistics, in 2019, CVD accounted for 25% of all deaths in the country¹.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

As part of the Roche Group, Roche Diagnostics Australia is a leading healthcare company that is committed to better outcomes for everyone in Australia.

For more information, please visit

Read more about our partnership here.